NATtrol Coxsackievirus A9
NATtrol Coxsackievirus A9 Stock (NATCXVA9-ST) is formulated with purified, intact virus particles that have been chemically modified to render them non-infectious and refrigerator stable. Each vial contains 1.0 mL of Coxsackievirus A9 NATtrol. NATCXVA9-ST stock is supplied in a purified protein matrix that mimics the composition of a true clinical specimen.
NATtrol Coxsackievirus A9 Stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of Coxsackievirus RNA. NATCXVA9-ST can also be used for validation of clinical assays, development of diagnostic tests and training of laboratory personnel. NATCXVA9-ST contains intact virus and should be run in a manner identical to that used for clinical specimens.
Qualitative – Real-Time PCR / +2Â° to +8Â° C.